Extracorporeal cardiopulmonary resuscitation | |
---|---|
Specialty | cardiology, cardiovascular-Surgery |
Extracorporeal cardiopulmonary resuscitation (commonly known as ECPR) is a method of cardiopulmonary resuscitation (CPR) that passes the patient's blood through a machine in a process to oxygenate the blood supply. A portable extracorporeal membrane oxygenation (ECMO) device is used as an adjunct to standard CPR. A patient who is deemed to be in cardiac arrest refractory to CPR has percutaneous catheters inserted into the femoral vein and artery. Theoretically, the application of ECPR allows for the return of cerebral perfusion in a more sustainable manner than with external compressions alone. [1] [2] By attaching an ECMO device to a person who has acutely undergone cardiovascular collapse, practitioners can maintain end-organ perfusion whilst assessing the potential reversal of causal pathology, with the goal of improving long-term survival and neurological outcomes.
Similar to the concept of elective cardiopulmonary bypass, used in open heart surgery, oxygenation and perfusion can be maintained with an ECMO device in patients undergoing cardiovascular collapse. In the setting of cardiac arrest, ECPR involves percutaneous cannulation of a femoral vein and artery, followed by the activation of the device, which subsequently maintains circulation until an appropriate recovery is made.[ citation needed ]
The theory behind this invasive approach is that the artificial restoration of oxygenation and end-organ perfusion allows treating physicians more time to mitigate and reverse pathology which contributes to cardiac arrest and refractory shock. It has been well documented that the likelihood of return of spontaneous circulation and furthermore eventual discharge from hospital, after ten minutes of CPR falls significantly. [3] [4] [5] Once circulation is established, the patient is able to be transferred, for further investigation and intervention, to facilities such as a cardiac cath lab and an intensive care unit.[ citation needed ]
Extracorporeal life support (ECLS) systems differ from traditional, theatre based, cardiac bypass machines in that they are portable and utilise percutaneous access as opposed to catheters which are surgically inserted into an open chest. The first access enters the femoral vein at the groin and is extended superiorly to the right atrium. The second line enters the ipsilateral or contralateral femoral artery and advanced to the distal aorta. Deoxygenated blood is removed from the right atrium prior to being pumped through the ECLS device where it is oxygenated and returned as retrograde flow to the distal aorta.[ citation needed ]
Depending on the indication for extracorporeal membrane oxygenation, there are two common set-ups: veno-arterial (VA) and veno-venous (VV). In some instances the initial set-up can be transferred to a hybrid set-up.[ citation needed ]
ECPR is largely viewed as a rescue therapy, which is initiated in patients in cardiac arrest or profound circulatory shock, for whom all conventional therapies have been exhausted and death without further support is imminent. This is based on the assertion that the rapid application of ECPR can temporarily support patients with cardiovascular collapse, whilst permitting an assessment of potential options to maximise long-term survival. [6] The American Heart Association cautiously surmises that in settings in which an experienced and accessible ECPR service is readily available, that it may be of benefit. The guidelines qualify this by advising that the patient should have had only a brief period without blood flow and that the condition resulting in the arrest be amenable to reversal i.e. hypothermia, intoxication or acute coronary insufficiency. [7] [8] [9] [10]
One of the most controversial topics associated with ECPR, is who is it indicated for. This factor has also been regarded as a major contributor of confounders to the numerous observational studies undertaken to assess to feasibility and appropriateness of ECPR.[ citation needed ]
Edecmo.org provides a simple three step criteria for patient selection when it comes to ECPR. [11] This includes:
The ECPR guidelines produced by Alfred Health provides a more detailed series of indications which considers the specific indications for both out-of-hospital cardiac arrest (OOHCA) and in-hospital cardiac arrest (IHCA). [12] - Note the following are specific to the above-mentioned site and are provided only as an example of an institution's guidelines.
Patients located within an appropriately equipped Accident and Emergency department with out-of-hospital cardiac arrest which is refractory to standard advanced cardiac life support (ACLS) treatment AND:[ citation needed ]
Patients with in-hospital cardiac arrest, which is refractory to standard, advanced cardiac life support (ACLS) treatment AND in whom the cause may be reversible, such as:[ citation needed ]
No precise list of contraindications has been established, though numerous studies and guidelines have adapted a range of circumstance in which the use of ECPR would be inappropriate. [12] [13]
The application of ECMO in any circumstance is technically difficult and invasive. The risk associated with the initial process of connecting a patient to an extracorporeal life support device is potentially exacerbated by the emergent nature of ECMO CPR.[ citation needed ]
Four recent observational studies reported complications in approximately one quarter of patients. [14] The studies included complication of the initial application and from remaining on the extracorporeal oxygenation circuit. [15] [16] [17] [18] The complications included:
The following protocol is an example of the site specific regime used as the basis of the CHEER trial [19] based at the Alfred Hospital (Melbourne, Victoria).
Once cardiac arrest is identified, cardiopulmonary resuscitation is commenced as per local resuscitation algorithms. With the assistance of emergency medical services and in hospital resuscitation teams, all patients with out-of hospital and in hospital arrests are assessed for their eligibility for ECPR. A set of criteria, specific to each ECMO site is applied whilst cardiac compressions are continued. The patients clinical history is reviewed to assess for a likely reversible cause associated with the arrest. Patients are also reviewed for the presence of contraindication such as pre-existing neurological impairment or significant limitation in ability to undertake activities of daily living. Patients who are deemed not suitable for ECPR continue on standard ALS protocols or in accordance to pre-existing advanced care directives.[ citation needed ]
Once a patient is deemed appropriate for ECPR, the appropriate ECPR team is alerted. Patients in the CHEER trial [19] had a mechanical compression device, the Autopulse (TM ZOLL Inc, MA USA) attached. Also specific to the CHEER trial is the infusion of 2L of ice-cold saline in an effort to induce hypothermia. The patient is intubated for ventilatory support, while they continue to be managed. [20]
On confirming the appropriateness of the patient as a candidate for ECPR and once the complete ECPR has been assembled the process of cannulation begins. With a brief pause in chest compressions, a modified Seldinger technique is used to access both the femoral artery and femoral vein with the assistance of ultrasound. In the CHEER trial [19] 15Fr arterial cannulae and 17Fr venous cannulae [21] (Medtronic, Minneapolis, MN USA) were used. The arterial cannula is advanced to the descending aorta, whilst the venous cannula is extended to the inferior vena cava. The positions of the respective guidewires is confirmed with a chest x-ray.[ citation needed ]
Once successful cannulation is confirmed, 5000 units of intravenous heparin is administered. The patients cannula are attached to an ECMO circuit with blood flow targets of 3Lmin−1 and oxygen blood flow of 3L min−1 commenced. An arterial blood gas is used to assess for successful oxygenation and metabolic improvement following the commencement of ECMO. In the CHEER trial, mean arterial perfusion pressures of 70mmHg were targeted. [19] Once the patient is stabilised on the ECMO circuit, they are transferred for further management of causal pathology, for example to the cardiac catheterisation laboratory for coronary angiogram or to radiology for thrombectomy. In an effort to avoid limb ischaemia, in some centres a third cannula is inserted. This third cannula, is extended distally into the femoral artery to ensure perfusion of the lower limb. It has been well established that maintenance of therapeutic hypothermia is arrest scenarios is beneficial. [22] [23] In view of this, a target temperature of 33°C is maintained for the first 24 hours following commencement of ECMO, with gradual rewarming occurring thereafter. [19]
The current trend of increasing use of ECPR is very promising. However the pool of available research of efficacy is limited, with a number of retrospective observational studies and prospective case-controls studies providing the foundation of modern ECPR evidence. Due to the very nature of ECPR, the applications of a randomised control trial is largely unfeasible, thus limited the quality of data available [24] [25] Furthermore, in regards to logistics, ECPR is a highly sub specialised procedure which is both resource and skill intensive. As such it is expensive to initiate and to maintain and therefore has exclusively occurred in tertiary centres with a well-established ECMO service. [26]
For the past two decades ECPR has been used, in paediatric populations, to good effect. Data collected over the same period reports a rate of survival to discharge of 40%. [27] [28] In the pediatric population the indication for ECPR is primarily due to cardiac collapse, often associated with congenital pathology. Similarly as with adults ECMO is only indicated if reversal of the pathology for example with cardiac transplantation, is feasible. [27] When it comes to the consideration of the withdrawal of ECMO, unlike in adult populations parents are encouraged to make the final decision with guidance from the treating physicians. The limitation associated with ECPR in the adult population, including a lack of evidence, resource intensity and the need for a well established and experienced ECPR service.[ citation needed ]
Cardiac arrest, also known as sudden cardiac arrest, is when the heart suddenly and unexpectedly stops beating. As a result, blood cannot properly circulate around the body and there is diminished blood flow to the brain and other organs. When the brain does not receive enough blood, this can cause a person to lose consciousness. Coma and persistent vegetative state may result from cardiac arrest. Cardiac arrest is also identified by a lack of central pulses and abnormal or absent breathing.
Cardiopulmonary resuscitation (CPR) is an emergency procedure consisting of chest compressions often combined with artificial ventilation, or mouth to mouth in an effort to manually preserve intact brain function until further measures are taken to restore spontaneous blood circulation and breathing in a person who is in cardiac arrest. It is recommended for those who are unresponsive with no breathing or abnormal breathing, for example, agonal respirations.
Clinical death is the medical term for cessation of blood circulation and breathing, the two criteria necessary to sustain the lives of human beings and of many other organisms. It occurs when the heart stops beating in a regular rhythm, a condition called cardiac arrest. The term is also sometimes used in resuscitation research.
Advanced cardiac life support, advanced cardiovascular life support (ACLS) refers to a set of clinical guidelines for the urgent and emergent treatment of life-threatening cardiovascular conditions that will cause or have caused cardiac arrest, using advanced medical procedures, medications, and techniques. ACLS expands on Basic Life Support (BLS) by adding recommendations on additional medication and advanced procedure use to the CPR guidelines that are fundamental and efficacious in BLS. ACLS is practiced by advanced medical providers including physicians, some nurses and paramedics; these providers are usually required to hold certifications in ACLS care.
Hypothermia is defined as a body core temperature below 35.0 °C (95.0 °F) in humans. Symptoms depend on the temperature. In mild hypothermia, there is shivering and mental confusion. In moderate hypothermia, shivering stops and confusion increases. In severe hypothermia, there may be hallucinations and paradoxical undressing, in which a person removes their clothing, as well as an increased risk of the heart stopping.
Asystole is the absence of ventricular contractions in the context of a lethal heart arrhythmia. Asystole is the most serious form of cardiac arrest and is usually irreversible. Also referred to as cardiac flatline, asystole is the state of total cessation of electrical activity from the heart, which means no tissue contraction from the heart muscle and therefore no blood flow to the rest of the body.
Extracorporeal membrane oxygenation (ECMO), is a form of extracorporeal life support, providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to provide an adequate amount of oxygen, gas exchange or blood supply (perfusion) to sustain life. The technology for ECMO is largely derived from cardiopulmonary bypass, which provides shorter-term support with arrested native circulation. The device used is a membrane oxygenator, also known as an artificial lung.
A cardiovascular perfusionist, clinical perfusionist or perfusiologist, and occasionally a cardiopulmonary bypass doctor or clinical perfusion scientist, is a healthcare professional who operates the cardiopulmonary bypass machine during cardiac surgery and other surgeries that require cardiopulmonary bypass to manage the patient's physiological status. As a member of the cardiovascular surgical team, the perfusionist also known as the clinical perfusionist helps maintain blood flow to the body's tissues as well as regulate levels of oxygen and carbon dioxide in the blood, using a heart–lung machine.
Advanced Life Support (ALS) is a set of life saving protocols and skills that extend basic life support to further support the circulation and provide an open airway and adequate ventilation (breathing).
ABC and its variations are initialism mnemonics for essential steps used by both medical professionals and lay persons when dealing with a patient. In its original form it stands for Airway, Breathing, and Circulation. The protocol was originally developed as a memory aid for rescuers performing cardiopulmonary resuscitation, and the most widely known use of the initialism is in the care of the unconscious or unresponsive patient, although it is also used as a reminder of the priorities for assessment and treatment of patients in many acute medical and trauma situations, from first-aid to hospital medical treatment. Airway, breathing, and circulation are all vital for life, and each is required, in that order, for the next to be effective: a viable Airway is necessary for Breathing to provide oxygenated blood for Circulation. Since its development, the mnemonic has been extended and modified to fit the different areas in which it is used, with different versions changing the meaning of letters or adding other letters.
An oxygenator is a medical device that is capable of exchanging oxygen and carbon dioxide in the blood of human patients during surgical procedures that may necessitate the interruption or cessation of blood flow in the body, a critical organ or great blood vessel. These organs can be the heart, lungs or liver, while the great vessels can be the aorta, pulmonary artery, pulmonary veins or vena cava.
Cardiothoracic anesthesiology is a subspeciality of the medical practice of anesthesiology, devoted to the preoperative, intraoperative, and postoperative care of adult and pediatric patients undergoing cardiothoracic surgery and related invasive procedures.
The Hs and Ts is a mnemonic used to aid in remembering the possible reversible causes of cardiac arrest. A variety of disease processes can lead to a cardiac arrest; however, they usually boil down to one or more of the "Hs and Ts".
Impella is a family of medical devices used for temporary ventricular support in patients with depressed heart function. Some versions of the device can provide left heart support during other forms of mechanical circulatory support including ECMO and Centrimag.
The Extracorporeal Life Support Organization (ELSO) is a non profit organization established in 1989 supporting health care professionals and scientists who are involved in extracorporeal membrane oxygenation (ECMO). ELSO maintains a registry of both facilities and specialists trained to provide ECMO services. ELSO also maintains registry information that is used to support clinical research, support regulatory agencies, and support individual ELSO centers. ELSO provides educational programs for active centers as well as for facilities who may be involved in the transfer of patients to higher levels of care.
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a minimally invasive procedure performed during resuscitation of critically injured trauma patients. Originally developed as a less invasive alternative to emergency thoracotomy with aortic cross clamping, REBOA is performed to gain rapid control of non-compressible truncal or junctional hemorrhage. REBOA is performed first by achieving access to the common femoral artery (CFA) and advancing a catheter within the aorta. Upon successful catheter placement, an occluding balloon may be inflated either within the descending thoracic aorta or infrarenal abdominal aorta. REBOA stanches downstream hemorrhage and improves cardiac index, cerebral perfusion, and coronary perfusion. Although REBOA does not eliminate the need for definitive hemorrhage control, it may serve as a temporizing measure during initial resuscitation. Despite the benefits of REBOA, there are significant local and systemic ischemic risks. Establishing standardized REBOA procedural indications and mitigating the risk of ischemic injury are topics of ongoing investigation. Although this technique has been successfully deployed in adult patients, it has not yet been studied in children.
Benjamin S. Abella is an American physician, emergency medicine practitioner, internist, academic and researcher. He is the William G. Baxt Professor and Vice Chair of Research at University of Pennsylvania’s Department of Emergency Medicine. He directs the Center for Resuscitation Science and the Penn Acute Research Collaboration at the University. He has participated in developing international CPR guidelines.
The Lund University Cardiopulmonary Assist System (LUCAS) device provides mechanical chest compressions to patients in cardiac arrest. It is mostly used in emergency medicine as an alternative to manual CPR because it provides consistent compressions at a fixed rate through difficult transport conditions and eliminates the physical strain on the person performing CPR. The first generation of the LUCAS device was pneumatic, while the second and third generations are battery-operated.
Post-cardiac arrest syndrome (PCAS) is an inflammatory state of pathophysiology that can occur after a patient is resuscitated from a cardiac arrest. While in a state of cardiac arrest, the body experiences a unique state of global ischemia. This ischemia results in the accumulation of metabolic waste which instigate the production of inflammatory mediators. If return of spontaneous circulation (ROSC) is achieved after CPR, then circulation resumes, resulting in global reperfusion and the subsequent distribution of the ischemia products throughout the body. While PCAS has a unique cause and consequences, it can ultimately be thought of as type of global ischemia-reperfusion injury. The damage, and therefore prognosis, of PCAS generally depends on the length of the patient's ischemic period; therefore the severity of PCAS is not uniform across different patients.